-

Morris & Dickson is the First U.S. Distributor for Bavarian Nordic’s JYNNEOS®, the Only FDA-approved Mpox Vaccine

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson is proud to announce it is the first U.S. distributor of Bavarian Nordic’s newly launched mpox vaccine, JYNNEOS®. As the only FDA-approved mpox vaccine, JYNNEOS is now commercially available in the U.S., marking a significant expansion for access.

Bavarian Nordic announced its commercial entry into the US on April 2, noting the ongoing need for the vaccine. Mpox (also known as monkeypox) is a viral disease that is part of the same family of viruses that causes smallpox. Mpox is rarely fatal, and its symptoms are similar to smallpox but milder. According to the Centers for Disease Control and Prevention (CDC), while mpox no longer constitutes a public health emergency, infections are still occurring throughout the U.S., with around 200 cases every month on average. Since the beginning of the outbreak in 2022, more than 32,000 cases have been reported in the U.S., representing a third of all cases reported globally.

Morris & Dickson is receiving the first U.S. shipment of JYNNEOS, which must be safely stored at negative 20 degrees Celsius (-20°C). This storage and transport capability is also a unique feature of Morris & Dickson’s state-of-the-art distribution techniques.

“We are proud to be a key partner in expanding access to this first-to-market vaccine,” says Layne Martin, head of Specialty at Morris & Dickson. “JYNNEOS meets a critical public health need and helps ensure equitable access to healthcare, which in turn helps significantly prevent the spread of mpox to at-risk populations.”

About Morris & Dickson

Morris & Dickson is the industry’s largest independent full-line and specialty pharmaceutical distributor with a singular focus of reliable, next-day delivery of drugs and related products to health systems, independent pharmacies, specialty pharmacies, and alternative care facilities across 27 states (and counting). Doing business the right way since 1841, Morris & Dickson continues to grow to meet customers’ needs with over 30,000 SKUs of pharmaceutical and healthcare products found in our state-of-the-art, 12-acre automated distribution center, located in Louisiana. For more information, please visit https://www.morrisdickson.com/news-insights/.

Contacts

Cassandra Johnson, SVP, Marketing
cjohnson@morrisdickson.com
(214) 288-5471

Morris & Dickson


Release Versions

Contacts

Cassandra Johnson, SVP, Marketing
cjohnson@morrisdickson.com
(214) 288-5471

More News From Morris & Dickson

Morris & Dickson and Mark Cuban Cost Plus Drugs: Pioneering a New Era in Medication Access

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson LLC, the nation’s largest independent pharmaceutical distributor, today announced a strategic partnership with Mark Cuban Cost Plus Drug Company and the Cost Plus Marketplace to significantly expand access to critical injectable medications nationwide, addressing key challenges for hospitals, pharmacies, clinics and healthcare providers alike. Transforming Healthcare Through Innovation At the heart of this collaboration lies a shared commit...

Morris & Dickson Announces Expansion of Third-Party Logistics Services with Acquisition of Presa Solutions

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson Inc., a pharmaceutical wholesale and specialty distributor, announced today the acquisition of Presa Solutions, a leading virtual third-party logistics (3PL) company for pharmaceutical manufacturers. This purchase will extend Morris & Dickson’s current service offering for pharmaceutical manufacturer customers with the addition of a 3PL platform that will combine Presa Solutions’ groundbreaking order-to-cash platform with Morris & D...

Morris & Dickson Continues Growth Trajectory with National Licensing for Distribution Across All 50 States

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson announced today that it is now licensed to deliver pharmaceuticals and related products to health systems, independent pharmacies, specialty pharmacies and alternative care facilities across all 50 states. With a 180-plus year reputation as the leading pharmaceutical distributor in the south-central region of the United States, this national expansion signifies a milestone in M&D’s growth strategy with the ability to serve pharmacies ac...
Back to Newsroom